97368273 - EVOMYO

Information

• Trademark
• 97368273

• Source

• Serial Number

  97368273

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  April 18, 2022
  2 years ago

• Transaction Date

  April 21, 2024
  a month ago

• Status Date

  June 15, 2023
  11 months ago

• Published for Opposition Date

  March 14, 2023
  a year ago

• Location Date

  June 15, 2023
  11 months ago

• Status Code

  604

• Current Location

  TTAB

  Employee Name

  LORENZO, GEORGE M

• Attorney Name

  MAURY M. TEPPER, III

  Law Office Assigned Location Code

  L10

• Owners

  • SAREPTA THERAPEUTICS, INC.

Case File Statements

• GS0051: Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases

Case File Event Statements

• 4/21/2022 - 2 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 4/25/2022 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 2/3/2023 - a year ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 2/8/2023 - a year ago

  4 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 2/22/2023 - a year ago

  5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 3/14/2023 - a year ago

  6 - PUBLISHED FOR OPPOSITION Type: PUBO

• 3/14/2023 - a year ago

  7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 4/10/2023 - a year ago

  8 - OPPOSITION PAPERS RECEIVED AT TTAB Type: OPPF

• 4/10/2023 - a year ago

  9 - OPPOSITION INSTITUTED NO. 999999 Type: OP.I

• 6/15/2023 - 11 months ago

  11 - OPPOSITION TERMINATED NO. 999999 Type: OP.T

• 6/15/2023 - 11 months ago

  10 - OPPOSITION DISMISSED NO. 999999 Type: OP.D

• 6/15/2023 - 11 months ago

  12 - ABANDONMENT - AFTER INTER PARTES DECISION Type: ABN4

• 6/15/2023 - 11 months ago

  13 - ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION Type: MAB4